Recently conducted studies have found a link between Seroquel and a higher risk of developing blood sugar disorders, including hyperglycemia, diabetic ketoacidosis, and diabetes. Diabetes is a metabolic condition in which the body cannot breakdown glucose properly. Experts estimate that at least 171 million individuals worldwide suffer from diabetes and the number is expected to double by 2030. In 2005, diabetes sufferers in the United States totaled 20.8 million people, and it is believed that there are over 6 million people with diabetes that have gone undiagnosed and another 41 million people who could be considered pre-diabetic.
The association between the usage of Seroquel and an increased risk of developing a blood sugar disorder led the FDA to request that the warning label on Seroquel be changed to include the new information. Seroquel is one of the 6 anti-psychotic medications believed to promote diabetes, high cholesterol, and obesity. The clinical trials conducted found that the patients taking Seroquel developed diabetes over three times more often than the patients who were taking anti-psychotic medications that had been on the market for a longer period of time. Doctors received information warning them to carefully monitor any of their patients who were taking Seroquel to determine whether they were developing diabetes. The risk was not determined to be great enough to warrant a recall of Seroquel, but healthcare professionals are advised to weight the risks and benefits carefully before deciding to prescribe Seroquel to any individual.
http://www.schmidtandclark.com/seroquel-diabetes
No comments:
Post a Comment